Triple-negative Breast Carcinoma (TNBC) Immunoncology also effective in Neoadjuvancy

被引：0
|
作者：
Freye, Reimund
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [21] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [22] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [23] Inducing cell state transitions in triple-negative breast cancer (TNBC).
    Loo, Ser Yue
    Toh, Liping
    Pathak, Elina
    Tan, Wilson
    Ma, Siming
    Yuan, Ju
    Periyasamy, Giridharan
    Torta, Federico
    Chan, Jack
    Tan, Tira
    Sim, Yi Rong
    Tan, Veronique
    Tan, Benita
    Madhukumar, Preetha
    Yong, Wei Sean
    Ong, Kong Wee
    Wong, Chow Yin
    Wenk, Markus R.
    Foo, Roger
    Yap, Yoon-Sim
    Lim, Elaine
    Tam, Wai Leong
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 73 - 73
  • [24] Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
    Sheng, Iris Y.
    Kruse, Megan
    Leininger, Kathryn M.
    Ornstein, Moshe C.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [25] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Cytologic features of triple-negative breast carcinoma
    Bonzanini, Mariella
    Morelli, Luca
    Bonandini, Elena Maria
    Leonardi, Elena
    Pertile, Riccardo
    Dalla Palma, Paolo
    CANCER CYTOPATHOLOGY, 2012, 120 (06) : 401 - 409
  • [27] Analysis of the JAK2 gene in triple-negative breast cancer (TNBC)
    Stanek, L.
    Tesarova, P.
    Vocka, M.
    Petruzelka, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)
    Song, J.
    Apple, S.
    Goodglick, L.
    Mah, V. H.
    Kim, S. R.
    Alavi, M. T.
    Chia, D.
    Deng, X.
    Chang, H. R.
    CANCER RESEARCH, 2013, 73
  • [29] Chemokine network between triple-negative breast cancer (TNBC) and non-TNBC cells.
    Gibbs, Carla
    Ignacio, Rosa
    Hyeong, Choi
    Son, Deok-Soo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 88 - 89
  • [30] Responses rates and outcome to neoadjuvant chemotherapy in triple-negative breast cancers (TNBC)
    Neciosup, S. P.
    Ventura, L.
    Gomez, H.
    Pinto, J. A.
    Marcelo, M. J.
    Vidaurre, T.
    Vallejos Sologuren, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345